Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease.
作者信息
Kupryś-Lipińska Izabela, Pałczyński Cezary, Molinska Joanna, Kuna Piotr
机构信息
Department of Internal Medicine, Asthma and Allergy, Norbert Barlicki Memorial University Hospital No. 1, Medical University of Lodz, Lodz, Poland.
Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
出版信息
Postepy Dermatol Alergol. 2019 Apr;36(2):239-241. doi: 10.5114/ada.2018.73140. Epub 2018 Feb 2.
Abstract
摘要
相似文献
1
Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease.奥马珠单抗治疗一名重度哮喘合并慢性阻塞性肺疾病患者
Postepy Dermatol Alergol. 2019 Apr;36(2):239-241. doi: 10.5114/ada.2018.73140. Epub 2018 Feb 2.
2
Should omalizumab be used in severe asthma/COPD overlap?奥马珠单抗是否应用于严重哮喘/COPD 重叠？
J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):755-761.
3
Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD.严重过敏性哮喘合并慢性阻塞性肺疾病患者的奥马珠单抗治疗反应
Chest. 2017 Jan;151(1):78-89. doi: 10.1016/j.chest.2016.09.035. Epub 2016 Oct 11.
4
Omalizumab treatment in asthma-COPD overlap syndrome.奥马珠单抗治疗哮喘-慢性阻塞性肺疾病重叠综合征
J Asthma. 2016 Dec;53(10):1048-50. doi: 10.1080/02770903.2016.1178281. Epub 2016 May 4.
5
Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels.奥马珠单抗（抗IgE）治疗哮喘-慢性阻塞性肺疾病重叠综合征（ACOS）及其对循环细胞因子水平的影响。
Immunopharmacol Immunotoxicol. 2016 Jun;38(3):253-6. doi: 10.3109/08923973.2016.1173057. Epub 2016 Apr 28.
6
Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.抗IgE单克隆抗体治疗重度持续性哮喘患者的临床病程及副作用
Clin Lab. 2013;59(1-2):71-7. doi: 10.7754/clin.lab.2012.120406.
7
Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab.使用奥马珠单抗治疗的重度过敏性哮喘患者中的2型自身免疫性多内分泌腺综合征
J Asthma. 2018 Dec;55(12):1384-1386. doi: 10.1080/02770903.2017.1414239. Epub 2018 Jan 4.
8
Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.奥马珠单抗控制下的重症哮喘表型：一项真实世界研究。
Respir Med. 2019 Nov;159:105804. doi: 10.1016/j.rmed.2019.105804. Epub 2019 Oct 21.
9
[OMALIZUMAB RESCUED A ASTHMA-COPD OVERLAP SYNDROME PATIENT FROM A STATUS ASTHMATICS UNDER THE ICU MANAGEMENT].[奥马珠单抗在重症监护病房管理下将一名哮喘-慢性阻塞性肺疾病重叠综合征患者从哮喘持续状态中解救出来]
Arerugi. 2016 Jul;65(7):937-41. doi: 10.15036/arerugi.65.937.
10
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis.奥马珠单抗治疗一名患有重度持续性哮喘并伴有嗜酸性食管炎的13岁男孩。
Ital J Pediatr. 2016 Mar 22;42:32. doi: 10.1186/s13052-016-0243-x.
引用本文的文献
1
Asthma-COPD Overlap in Clinical Practice (ACO_CP 2023): Toward Precision Medicine.临床实践中的哮喘-慢性阻塞性肺疾病重叠（ACO_CP 2023）：迈向精准医学
J Pers Med. 2023 Apr 18;13(4):677. doi: 10.3390/jpm13040677.
2
Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions.哮喘-慢性阻塞性肺疾病重叠综合征：最新见解与未解决的问题
J Pers Med. 2022 Apr 28;12(5):708. doi: 10.3390/jpm12050708.
本文引用的文献
1
[OMALIZUMAB RESCUED A ASTHMA-COPD OVERLAP SYNDROME PATIENT FROM A STATUS ASTHMATICS UNDER THE ICU MANAGEMENT].[奥马珠单抗在重症监护病房管理下将一名哮喘-慢性阻塞性肺疾病重叠综合征患者从哮喘持续状态中解救出来]
Arerugi. 2016 Jul;65(7):937-41. doi: 10.15036/arerugi.65.937.
2
Omalizumab treatment in asthma-COPD overlap syndrome.奥马珠单抗治疗哮喘-慢性阻塞性肺疾病重叠综合征
J Asthma. 2016 Dec;53(10):1048-50. doi: 10.1080/02770903.2016.1178281. Epub 2016 May 4.
3
Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels.奥马珠单抗（抗IgE）治疗哮喘-慢性阻塞性肺疾病重叠综合征（ACOS）及其对循环细胞因子水平的影响。
Immunopharmacol Immunotoxicol. 2016 Jun;38(3):253-6. doi: 10.3109/08923973.2016.1173057. Epub 2016 Apr 28.
4
The effect of Varenicline on smoking cessation in a group of young asthma patients.伐尼克兰对一组年轻哮喘患者戒烟的影响。
Respir Med. 2015 Nov;109(11):1416-22. doi: 10.1016/j.rmed.2015.07.017. Epub 2015 Jul 30.
5
Control of asthma in adults treated with beclomethasone and formoterol in extrafine particle formulation in a real-life setting in Poland: the CASPER noninterventional, observational trial.在波兰的实际环境中，使用布地奈德福莫特罗超细颗粒制剂治疗的成人哮喘控制情况：CASPER非干预性观察性试验
Pol Arch Med Wewn. 2015;125(10):731-40. doi: 10.20452/pamw.3111. Epub 2015 Sep 24.
6
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.接受奥马珠单抗治疗的重度哮喘患者的哮喘控制情况：意大利的一项横断面观察性研究。
Pulm Pharmacol Ther. 2015 Apr;31:123-9. doi: 10.1016/j.pupt.2014.09.007. Epub 2014 Sep 30.
7
Smoking influences response to inhaled corticosteroids in patients with asthma: a meta-analysis.吸烟影响哮喘患者吸入皮质类固醇的反应：荟萃分析。
Curr Med Res Opin. 2012 Nov;28(11):1791-8. doi: 10.1185/03007995.2012.722991. Epub 2012 Oct 22.
8
Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.奥马珠单抗治疗重度哮喘：来自西班牙注册研究的经验——一些新方法
J Asthma. 2012 May;49(4):416-22. doi: 10.3109/02770903.2012.668255. Epub 2012 Mar 23.
9
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.哮喘吸烟者在布地奈德/福莫特罗维持和缓解治疗中获益是否与非吸烟者一样多？一项开放标签研究的结果。
Respir Med. 2012 Feb;106(2):189-96. doi: 10.1016/j.rmed.2011.10.017. Epub 2011 Nov 26.
10
Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke.氟替卡松/沙美特罗联合治疗可使吸烟哮喘患者获益。
Chest. 2012 Feb;141(2):330-338. doi: 10.1378/chest.11-0392. Epub 2011 Jun 2.
Zotero 插件